The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity
Open accessAbstract
Background Cardiovascular (CV) disease has a major impact on patients with rheumatoid arthritis (RA), however, the relative contributions of traditional CV risk factors and markers of RA severity are unclear. The authors examined the relative importance of traditional CV risk factors and RA markers in predicting CV events. Methods A prospective longitudinal cohort study was conducted in the setting of the CORRONA registry in the USA. Baseline data from subjects with RA enrolled in the CORRONA registry were examined to determine predictors of CV outcomes, including myocardial infarction, stroke or transient ischemic attack. Possible predictors were of two types: traditional CV risk factors and markers of RA severity. The discriminatory value of these variables was assessed by calculating the area under the receiver operating characteristic curve (c-statistic) in logistic regression. The authors then assessed the incidence rate for CV events among subjects with an increasing number of traditional CV risk factors and/or RA severity markers. Results The cohort consisted of 10 156 patients with RA followed for a median of 22 months. The authors observed 76 primary CV events during follow-up for a composite event rate of 3.98 (95% CI 3.08 to 4.88) per 1000 patient-years. The c-statistic improved from 0.57 for models with only CV risk factors to 0.67 for models with CV risk factors plus age and gender. The c-statistic improved further to 0.71 when markers of RA severity were also added. The incidence rate for CV events was 0 (95% CI 0 to 5.98) for persons without any CV risk factors or markers of RA severity, while in the group with two or more CV risk factors and three or more markers of RA severity the incidence was 7.47 (95% CI 4.21 to 10.73) per 1000 person-years. Conclusions Traditional CV risk factors and markers of RA severity both contribute to models predicting CV events. Increasing numbers of both types of factors are associated with greater risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,112
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004
Ong, K. L., Cheung, B. M. Y., Man, Y. B., Lau, C. P., & Lam, K. S. L. (2007) · Hypertension · doi:10.1161/01.hyp.0000252676.46043.18 · Cited by 1,395 · cited 1×
“Third, detailed data on actual blood pressure and lipid measurements were not collected and thus it is possible that hypertension and hyperlipidemia were under-reported. Literature estimates of hypertension and hyperlipidemia in similar cohorts argues against under-reporting.”
BackgroundPeters, M. J. L., Symmons, D. P. M., McCarey, D., Dijkmans, B. A. C., Nicola, P., Kvien, T. K., McInnes, I. B., Haentzschel, H., Gonzalez-Gay, M. A., Provan, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.113696 · Cited by 1,325
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis
Solomon, D. H., Karlson, E. W., Rimm, E. B., Cannuscio, C. C., Mandl, L. A., Manson, J. E., Stampfer, M. J., & Curhan, G. C. (2003) · Circulation · doi:10.1161/01.cir.0000054612.26458.b2 · Cited by 1,246
Self-citationMethotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127
Aletaha, D., Nell, V. P., Stamm, T., Uffmann, M., Pflugbeil, S., Machold, K., & Smolen, J. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1740 · Cited by 1,068
Maradit‐Kremers, H., Crowson, C. S., Nicola, P. J., Ballman, K. V., Roger, V. L., Jacobsen, S. J., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20853 · Cited by 927
Aletaha, D., & Smolen, J. S. (2005) · PubMed · Cited by 843
McCarey, D. W., McInnes, I. B., Madhok, R., Hampson, R., Scherbakova, O., Ford, I., Capell, H. A., & Sattar, N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16449-0 · Cited by 818
Hürlimann, D., Forster, A., Noll, G., Enseleit, F., Chenevard, R., Distler, O., Béchir, M., Spieker, L. E., Neidhart, M., Michel, B. A., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037521.71373.44 · Cited by 574
Dixon, W. G., Watson, K. D., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22809 · Cited by 562
Patterns of cardiovascular risk in rheumatoid arthritis
Solomon, D. H., Goodson, N. J., Katz, J. N., Weinblatt, M. E., Avorn, J., Setoguchi, S., Canning, C., & Schneeweiss, S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.050377 · Cited by 412
Self-citationGoodson, N. J., Wiles, N. J., Lunt, M., Barrett, E. M., Silman, A. J., & Symmons, D. P. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10419 · Cited by 366
van Halm, V. P., Peters, M. J. L., Voskuyl, A. E., Boers, M., Lems, W. F., Visser, M., Stehouwer, C. D. A., Spijkerman, A. M. W., Dekker, J. M., Nijpels, G., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094151 · Cited by 359
Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis.
Wolfe, F., Freundlich, B., & Straus, W. L. (2003) · PubMed · Cited by 355
Chung, C. P., Oeser, A., Raggi, P., Gebretsadik, T., Shintani, A. K., Sokka, T., Pincus, T., Avalos, I., & Stein, C. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21288 · Cited by 354
del Rincón, I., Williams, K., Stern, M. P., Freeman, G. L., O'Leary, D. H., & Escalante, A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11078 · Cited by 353
Sempos, C. T. (1993) · JAMA · doi:10.1001/jama.269.23.3009 · Cited by 351
Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis
Gabriel, S. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.06.011 · Cited by 315
Model Selection for Extended Quasi-Likelihood Models in Small Samples
Hurvich, C. M., & Tsai, C.-L. (1995) · Biometrics · doi:10.2307/2533006 · Cited by 305
Goodson, N. J., Symmons, D. P. M., Scott, D. G. I., Bunn, D., Lunt, M., & Silman, A. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21204 · Cited by 287
van Halm, V. P., Nurmohamed, M. T., Twisk, J. W., Dijkmans, B. A., & Voskuyl, A. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2045 · Cited by 267
Goodson, N., Marks, J., Lunt, M., & Symmons, D. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.034777 · Cited by 248
del Rincón, I., Freeman, G. L., Haas, R. W., O'Leary, D. H., & Escalante, A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21397 · Cited by 244
Solomon, D. H., Avorn, J., Katz, J. N., Weinblatt, M. E., Setoguchi, S., Levin, R., & Schneeweiss, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22255 · Cited by 181
Self-citationWolfe, F., & Michaud, K. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23811 · Cited by 166
European biologicals registers: methodology, selected results and perspectives
Zink, A., Askling, J., Dixon, W. G., Klareskog, L., Silman, A. J., & Symmons, D. P. M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091926 · Cited by 142
Choi, H. K., & Seeger, J. D. (2005) · PubMed · Cited by 122
Dessein, P. H., Norton, G. R., Woodiwiss, A. J., Joffe, B. I., & Wolfe, F. (2007) · PubMed · Cited by 79
Kremer, J. M. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.07.006 · Cited by 70
Self-citationComposite scoring--methods and predictive validity: insights from the Framingham Study.
Kannel, W. B., & McGee, D. (1987) · PubMed Central · Cited by 32
Joyal, D., & Arab, D. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.01.005 · Cited by 32
Cited by
Agca, R., Heslinga, S. C., Rollefstad, S., Heslinga, M., McInnes, I. B., Peters, M. J. L., Kvien, T. K., Dougados, M., Radner, H., Atzeni, F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209775 · Cited by 1,380
Dougados, M., Soubrier, M., Antunez, A., Balint, P., Balsa, A., Buch, M. H., Casado, G., Detert, J., El-zorkany, B., Emery, P., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204223 · Cited by 855
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
“These data suggest that in an individual RA patient, LDL-C levels may increase when RA disease activity is controlled.(728,729) Although the overall reduction in inflammation is likely associated with reduced cardiovascular risk, the clinical significance of these lipid elevations with regards to cardiovascular risk h…”
BackgroundJBS3 Board (2014) · Heart · doi:10.1136/heartjnl-2014-305693 · Cited by 608
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
England, B. R., Thiele, G. M., Anderson, D. R., & Mikuls, T. R. (2018) · BMJ · doi:10.1136/bmj.k1036 · Cited by 609
Metadata
- Authors
- Solomon, D. H., Kremer, J., Curtis, J. R., Hochberg, M. C., Reed, G., Tsao, P., Farkouh, M. E., Setoguchi, S., & Greenberg, J. D.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 69
- Issue
- 11
- Pages
- 1920-1925
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W1990795149
- Cited by
- 297
- References
- 42
- FWCI
- 14.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.